JBCHEPHARM Shareholding Pattern
- Market cap
- ₹38,793 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹1,739.59 – ₹3,261.74
As of Jun 2026, promoters held 48.50% of JBCHEPHARM, foreign institutional investors 18.40%, domestic institutions 14.20% and the public 18.90%.
Source: Shareholding patterns filed with the stock exchanges (company filings). Data as of 9 October 2026. How this data is compiled.
JBCHEPHARM shareholding pattern — frequently asked questions
What is the promoter holding in JBCHEPHARM?
Promoters held 48.50% of JBCHEPHARM as of Jun 2026.
How much do FIIs hold in JBCHEPHARM?
Foreign institutional investors held 18.40% of JBCHEPHARM as of Jun 2026.
How much do domestic institutions hold in JBCHEPHARM?
Domestic institutional investors, including mutual funds and insurers, held 14.20% of JBCHEPHARM as of Jun 2026; mutual funds alone held 8.50%.
Who owns JBCHEPHARM?
As of Jun 2026, JBCHEPHARM's shareholders were promoters (48.50%), foreign institutional investors 18.40%, domestic institutions 14.20% and the public 18.90%, as filed with the stock exchanges.
Same Data For Peers
Trade JBCHEPHARM With ATS
Track JBCHEPHARM live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.